High-multiplexing quantitative CodePlex proteomic profiling of platelets in triple-negative breast cancer (TNBC) patients and healthy subjects.
Han E, Gu S, Steinle M, Gu V, Tyagi T, Mackay S, Hwa J, Zhou J. High-multiplexing quantitative CodePlex proteomic profiling of platelets in triple-negative breast cancer (TNBC) patients and healthy subjects. Journal Of Clinical Oncology 2022, 40: e15017-e15017. DOI: 10.1200/jco.2022.40.16_suppl.e15017.Peer-Reviewed Original ResearchTriple-negative breast cancerTriple-negative breast cancer patientsBreast cancer patientsCancer patientsHealthy controlsIL-8IL-9TNBC patientsPilot studyNegative breast cancer patientsAberrant platelet activationPlatelet releasateDifferential cytokine profilesPlatelet lysateNegative breast cancerSmall pilot studySerum/plasmaImmune panelMinimal IFNIL-17AMIP-1aCytokine profileIL-10IL-15Healthy patients